1. United Kingdom Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Provexis PLC

Provexis PLC

LLSE:PXS
0.95
GBX
+0.05
(+5.56%)
1.45BMarket Cap

Total Valuation

GBX

As of September 30, 2025, Provexis PLC carries a market capitalization of 1.45B, placing it among publicly traded companies globally. Its enterprise value stands at 1.34B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.45B
Enterprise Value1.34B

Share Statistics

As of September 30, 2025, Provexis PLC has 2.35B shares outstanding.

Shares Outstanding2.35B

Valuation Ratios

These figures are as of September 30, 2025.

PB Ratio12.66
P/TBV Ratio12.66

Financial Position

As of September 30, 2025, Provexis PLC maintains a current ratio of 3.65, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.

Current Ratio3.65
Quick Ratio2.27

Financial Efficiency

These figures cover the twelve months ended September 30, 2025.

Employee Count2.00

Stock Price Statistics

GBX

As of the close on October 22, 2026, Provexis PLC's stock has gained approximately 53.85% over the past 52 weeks. The 50-day moving average sits at 1.01, while the 200-day moving average is 1.10.

52-Week Price Change53.85%
50-Day Moving Average1.01
200-Day Moving Average1.10

Balance Sheet

GBX

These figures are as of September 30, 2025. Total book value stands at 114.46M, with working capital of 61.09M providing operational flexibility.

Cash & Cash Equivalents52.33M
Net Debt-52.33M
Equity (Book Value)114.46M
Book Value Per Share0.05
Working Capital61.09M

Stock Splits

Provexis PLC's most recent stock split took place on July 6, 2011.

Last Split Date7/6/2011